Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb;34(2):597-599.
doi: 10.1007/s00192-022-05314-2. Epub 2022 Aug 2.

Pain following injection of urethral elastomer bulking agent

Dvorak Jan  1 , Svabík Kamil  1 , Masata Jaromir  2
Affiliations

Pain following injection of urethral elastomer bulking agent

Dvorak Jan et al. Int Urogynecol J. 2023 Feb.
No abstract available

Keywords: Bulking agent; Incontinence; Urolastic.

PubMed Disclaimer

References

    1. Hoe V, Haller B, Yao H, O'Connell H. Urethral bulking agents for the treatment of stress urinary incontinence in women: A systematic review. Neurourol Urodynam. 2021;40(6):1349–88. - DOI
    1. Futyma K, Nowakowski Ł, Gałczyński K, Miotła P, Rechberger T. Nonabsorbable urethral bulking agent — clinical effectiveness and late complications rates in the treatment of recurrent stress urinary incontinence after 2 years of follow-up. Eur J Obstet Gynecol Reproductive Biol. 2016;207:68–72. - DOI
    1. Capobianco G, Azzena A, Saderi L, Dessole F, Dessole S, Sotgiu G. Urolastic®, a new bulking agent for treatment of stress urinary incontinence: a systematic review and meta-analysis. Int Urogynecol J. 2018;29(9):1239–47. - DOI
    1. Casteleijn F, Kowalik C, Berends C, Blaganje M, Lasić Pecev M, Linden E, et al. Patients' satisfaction and safety of bulk injection therapy Urolastic for treatment of stress urinary incontinence: A cross-sectional study. Neurourol Urodynam. 2020;39(6):1753–63. - DOI

LinkOut - more resources